| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |